Analyzing Hgk Asset Management's Q4 2022 vs. Q1 2023 Investment Holdings

Hgk Asset Management, Inc. is known for its consistent investment strategy and its ability to outperform market returns. The company has recently released its 13F holdings report for Q4 2022 and Q1 2023, revealing some exciting changes in its portfolio.

In this blog post, we'll take a closer look at the highlights of the report and analyze how these changes may impact the market in the future.

JPMorgan Chase & Co

JPMorgan Chase & Co remains Hgk Asset Management's top pick, increasing their holdings by 8,333 to 61,267 shares. The value of the company's holdings in JP Morgan Chase & Co increased by 12.5% from quarter four 2022 to quarter one 2023. JP Morgan Chase & Co is a financial services company that offers a range of financial services such as investment banking, trading, and asset management.

Johnson & Johnson

Johnson & Johnson is one of the most well-respected companies in the healthcare industry. Hgk Asset Management increased its position in the company by 18.94% to 45,025 shares. The value of the company's holdings in Johnson & Johnson increased by 4.5% from Q4 2022 to Q1 2023.

Abbvie Inc.

Hgk Asset Management increased its position in Abbvie Inc. by 6.3% to 41,157 shares, and the value of its holdings in Abbvie Inc. increased by 4.9% from Q4 2022 to Q1 2023. Abbvie Inc. is a pharmaceutical company that focuses on developing treatments for immunology, oncology, and neuroscience.

NRG Energy Inc.

NRG Energy Inc. is a power company that provides electricity to homes and businesses in the United States. Hgk Asset Management increased its holdings in the company by 36.4% to 191,154 shares, and the value of its holdings in NRG Energy Inc. increased by 47% from Q4 2022 to Q1 2023.

Zebra Technologies

Zebra Technologies is a leading provider of enterprise-level data capture and automatic identification solutions. Hgk Asset Management increased its position in the company by 6.6% to 20,091 shares, with the value of its holdings increasing by 32.2% from Q4 2022 to Q1 2023.

Constellation Brands

Constellation Brands owns and operates a portfolio of beer, wine, and spirits brands. Hgk Asset Management increased its position in the company by 36.6% to 27,501 shares, with the value of its holdings increasing by 33.1% from Q4 2022 to Q1 2023.

MetLife Inc.

MetLife Inc. is one of the largest life insurance companies in the world. Hgk Asset Management increased its holdings in the company by 19.35% to 106,989 shares, but the value of its holdings decreased by 4.6% from Q4 2022 to Q1 2023.

Bristol-Myers Squibb

Bristol-Myers Squibb is a leading biopharmaceutical company that focuses on developing treatments for cancer, heart disease, and HIV. Hgk Asset Management increased its position in the company by 20.5% to 88,262 shares, with the value of its holdings increasing by 16.2% from Q4 2022 to Q1 2023.

Cisco Systems Inc.

Cisco Systems Inc. is one of the largest providers of networking equipment and software in the world. Hgk Asset Management increased its position in the company by 19.81% to 114,798 shares, with the value of its holdings increasing by 31.5% from Q4 2022 to Q1 2023.

The Bottom Line

Hgk Asset Management's 13F report reveals an interesting mix of companies in different sectors. The increase in holdings in companies like JP Morgan Chase & Co, Johnson & Johnson, and Abbvie Inc. shows a bullish outlook for the financial, healthcare, and pharmaceutical sectors. The increase in holdings in NRG Energy, Zebra Technologies, and Constellation Brands shows a growing interest in energy, technology, and consumer goods.

Overall, this report confirms Hgk Asset Management's commitment to a diversified investment portfolio. It is also a good reflection of the current state of the stock market – despite volatility and uncertainty, there are still opportunities for growth and profitability.